|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flow from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Shares and warrants issued to third-parties for services | |||||
| Loss of disposal of assets | |||||
| Depreciation and amortization | |||||
| Amortization of debt issuance costs and discounts | |||||
| Goodwill impairment | |||||
| Intangible asset impairment | |||||
| Impairment of goodwill | |||||
| Impairment of intangibles | |||||
| Deferred tax expense | |||||
| Share-based compensation | |||||
| Amortization of prepaid assets | |||||
| Inventory reserve | |||||
| Bad debt expense | |||||
| PIK interest expense on term loan | |||||
| Accreted interest expense on term loan | |||||
| Bargain purchase gain | |||||
| Debt discount amortization | |||||
| Loss on settlement of accounts payable | |||||
| Loss on sale of cryptocurrency assets | |||||
| Other | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Other | |||||
| Accrued and other liabilities | |||||
| Cash Used in Operating Activities | |||||
| Cash Flow from Investing Activities: | |||||
| Capital expenditures | |||||
| Notes receivable | |||||
| Purchase of cryptocurrency | |||||
| Proceeds from sale of cryptocurrency | |||||
| Cash acquired in business combination | |||||
| Cash Provided by (Used in) Investing Activities | |||||
| Cash Flow from Financing Activities: | |||||
| Proceeds from equity offering | |||||
| Share repurchases | |||||
| Proceeds from long-term borrowings | |||||
| Repayment of long-term borrowings | |||||
| Proceeds from term loan | |||||
| Payments on term loans | |||||
| Cash received for warrant exercises | |||||
| IPO proceeds, net | |||||
| Proceeds from short-term borrowings | |||||
| Payments on short-term financing arrangement | |||||
| Proceeds from Wintrust facility | |||||
| Payments on Wintrust facility | |||||
| Payments on line of credit | |||||
| Repayment on short-term borrowings | |||||
| Proceeds from issuance of convertible debt | |||||
| Repayment of convertible debt | |||||
| Cash paid for financing costs | |||||
| Proceeds from PIPE | |||||
| Payments for share repurchase | |||||
| Payment of loan issuance costs | |||||
| Cash Provided by Financing Activities | |||||
| Net cash provided by (used in) continuing operations | |||||
| Net cash used in discontinued operations | |||||
| Net increase (decrease) in cash | |||||
| Effect of foreign currency translation adjustments | |||||
| Total cash and cash equivalents, beginning of period | |||||
| Total cash and cash equivalents, end of period | |||||
| Supplemental schedule of cash flow information: | |||||
| Income taxes | |||||
| Cash paid for interest during the period | |||||
| Reclassification of warrants to equity | |||||
| Alphia term loan forgiveness, see Note 9 - Debt | |||||
| Forgiveness of PIK interest on Alphia term loan, see Note 9 - Debt | |||||
| Write off of debt issuance costs | |||||
Loading...
